This is a demo store. No orders will be fulfilled.
USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
This issue profiles an aortic regurgitation measurement tool, a single scan breast imaging system, and spectroscopic measurement of haemoglobin.
$950.00 -
This issue profiles drug development in oncology using personalized medicine and companion diagnostics, immunotherapeutic candidate development for metastatic melanoma, and next generation vaccinations for infectious diseases.
$250.00 -
This issue profiles auto builders fortifying their R&D facilities in Silicon Valley, a next-generation cardiovascular device to treat coronary artery diseas, and doubling lithium-ion battery energy using ultra-thin anodes.
$250.00 -
This issue profiles enhancement of T-cell therapy using oncolytic viruses, utilizing T-cell therapy for restricting brain tumors, and a novel autologous cell therapy that uses chimeric antigen receptors.
$250.00 -
This issue profiles a cardiac monitor for remote patient monitoring, health information solutions for patient engagement, and a mechatronic exoskeleton to aid physical rehabilitation.
$950.00 -
This issue profiles a vaccine treatment for meningococcal disease that obtains FDA clearance, a nasal testosterone replacement therapy to treat male hypogonadism, and an injection therapy to control hypocalcemia in patients with hypoparathyroidism.
$950.00 -
13 Feb 2015 | Global | Technology Alert
Futuretech Alert. Biosensors--The Key to Organs on a Chip
This issue profiles developments, drivers, challenges, and applications of biosensors in healthcare.
$750.00 -
This issue profiles a promising gene therapy for beta thalassemia patients, a nanoparticle gene therapy for brain tumors, and a genetic predictor protein for gestational diabetes.
$250.00 -
This issue profiles identification of the gene responsible for microcephaly, a protein receptor responsible for allergic reactions, and a novel gene type related to retinitis pigmentosa.
$250.00 -
This issue profiles tattoo-based noninvasive glucose monitoring devices, cloud-based predictive technology, and combining photo acoustic imaging with ultrasonics for point-of-care diagnostics.
$250.00
